Literature DB >> 15572980

Dextromethorphan abuse.

Edward W Boyer1.   

Abstract

Dextromethorphan is an over-the-counter dissociative agent of increasing popularity as a drug of abuse among younger adolescents. The drug produces a range of toxicities depending upon either the dose or the components of the specific formulation that was ingested. Most cases improve with supportive care alone, but severely intoxicated patients may require significant attention. Because dextromethorphan is misused primarily by younger adolescents, the early identification and treatment of dextromethorphan abuse may be important in preventing broader substance abuse in these children. Consequently, it is important for clinicians to recognize, treat, and appropriately refer those who present with intoxication from this drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572980     DOI: 10.1097/01.pec.0000148039.14588.d0

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  11 in total

1.  Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsieh Chu; Nian-Sheng Tzeng; I-Hui Lee; Po-See Chen; Tzung Lieh Yeh; San-Yuan Huang; Yen-Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-23       Impact factor: 4.147

Review 2.  Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review.

Authors:  Andrew A Monte; Ryan Chuang; Michael Bodmer
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

3.  High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Authors:  Chad J Reissig; Lawrence P Carter; Matthew W Johnson; Miriam Z Mintzer; Margaret A Klinedinst; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2012-04-13       Impact factor: 4.530

4.  Ten Years of Robotripping: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User.

Authors:  Travis D Olives; Sean P Boley; Jenna M LeRoy; Samuel J Stellpflug
Journal:  J Med Toxicol       Date:  2019-03-22

Review 5.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

6.  Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

Authors:  Lawrence P Carter; Chad J Reissig; Matthew W Johnson; Margaret A Klinedinst; Roland R Griffiths; Miriam Z Mintzer
Journal:  Drug Alcohol Depend       Date:  2012-09-16       Impact factor: 4.492

7.  Perioperative Dextromethorphan as an Adjunct for Postoperative Pain: A Meta-analysis of Randomized Controlled Trials.

Authors:  Michael R King; Karim S Ladha; Amanda M Gelineau; T Anthony Anderson
Journal:  Anesthesiology       Date:  2016-03       Impact factor: 7.892

Review 8.  When good times go bad: managing 'legal high' complications in the emergency department.

Authors:  Charles R Caffrey; Patrick M Lank
Journal:  Open Access Emerg Med       Date:  2017-12-20

9.  Signs & symptoms of Dextromethorphan exposure from YouTube.

Authors:  Michael Chary; Emily H Park; Andrew McKenzie; Julia Sun; Alex F Manini; Nicholas Genes
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

Review 10.  Antitussives and substance abuse.

Authors:  Jarrett M Burns; Edward W Boyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.